SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $419,234,587 | +1.4% | 3,660,798 | +22.0% | 10.27% | -22.8% |
Q1 2023 | $413,414,607 | +6.4% | 2,999,453 | 0.0% | 13.31% | +12.5% |
Q4 2022 | $388,669,120 | +17.2% | 2,999,453 | 0.0% | 11.83% | +20.9% |
Q3 2022 | $331,560,000 | +54.2% | 2,999,453 | +4.6% | 9.79% | +31.9% |
Q2 2022 | $214,996,000 | +33.0% | 2,868,145 | +38.6% | 7.42% | +46.7% |
Q1 2022 | $161,680,000 | +1031.3% | 2,069,634 | +990.7% | 5.06% | +180.2% |
Q3 2019 | $14,292,000 | – | 189,745 | – | 1.80% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |